Cargando…

REAC Neuromodulation Treatments in Depression, Anxiety and Stress. A Comparative Retrospective Study

INTRODUCTION: The purpose of this retrospective study was to compare the effects of two different modalities of administration of the neuro psycho physical optimization (NPPO) neuromodulation treatment, applied with radio electric asymmetric conveyer (REAC) biotechnology devices. Both the modalities...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinheiro Barcessat, Ana Rita, Nolli Bittencourt, Marina, Góes Gonçalves, Rebeca, Goncalves de Oliveira Cruz, Ana Vitoria, Coelho Pereira, José Alfredo, Bechelli, Fabio Augusto, Rinaldi, Arianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762445/
https://www.ncbi.nlm.nih.gov/pubmed/33376420
http://dx.doi.org/10.2147/PRBM.S287143
_version_ 1783627807444697088
author Pinheiro Barcessat, Ana Rita
Nolli Bittencourt, Marina
Góes Gonçalves, Rebeca
Goncalves de Oliveira Cruz, Ana Vitoria
Coelho Pereira, José Alfredo
Bechelli, Fabio Augusto
Rinaldi, Arianna
author_facet Pinheiro Barcessat, Ana Rita
Nolli Bittencourt, Marina
Góes Gonçalves, Rebeca
Goncalves de Oliveira Cruz, Ana Vitoria
Coelho Pereira, José Alfredo
Bechelli, Fabio Augusto
Rinaldi, Arianna
author_sort Pinheiro Barcessat, Ana Rita
collection PubMed
description INTRODUCTION: The purpose of this retrospective study was to compare the effects of two different modalities of administration of the neuro psycho physical optimization (NPPO) neuromodulation treatment, applied with radio electric asymmetric conveyer (REAC) biotechnology devices. Both the modalities are aimed at improving the strategies to deal with and optimize the allostatic response to environmental stressors and exposome. This allows to reduce the dysfunctional adaptive behavior patterns, which underlie many neuropsychological symptoms and pathologies, and to improve the symptoms of depression, anxiety and stress. MATERIALS AND METHODS: From a population of subjects experiencing at least two of the three symptoms depression, anxiety and stress, the selection of pre and post-treatment Depression, Anxiety, Stress 21 items scale (DASS 21) data was made proceeding with a reverse chronological recruitment mechanism, until reaching 150 subjects for each of the 2 groups. The first group was treated with the neuro psycho physical optimization treatment (NPPO), which is the punctiform modality of administration on the auricle pavilion, and the second group was treated with the neuro psycho physical optimization treatment, which is the area modality of administration applied by the planar probe on the cervicobrachial area (NPPO-CB). RESULTS: The Wilcoxon signs test confirmed the differences in scores in pre and post-treatment DASS-21. The comparison between the two groups data and the comparison across groups data showed that NPPO and NPPO-CB have the same efficacy in reducing the symptoms of depression, anxiety and stress, after a single treatment cycle. Statistical significance was set at p <0.05. DISCUSSION: This is the first efficacy descriptive comparison between the two different modalities of administration of the NPPO treatment, as different options for the same clinical indication.
format Online
Article
Text
id pubmed-7762445
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-77624452020-12-28 REAC Neuromodulation Treatments in Depression, Anxiety and Stress. A Comparative Retrospective Study Pinheiro Barcessat, Ana Rita Nolli Bittencourt, Marina Góes Gonçalves, Rebeca Goncalves de Oliveira Cruz, Ana Vitoria Coelho Pereira, José Alfredo Bechelli, Fabio Augusto Rinaldi, Arianna Psychol Res Behav Manag Original Research INTRODUCTION: The purpose of this retrospective study was to compare the effects of two different modalities of administration of the neuro psycho physical optimization (NPPO) neuromodulation treatment, applied with radio electric asymmetric conveyer (REAC) biotechnology devices. Both the modalities are aimed at improving the strategies to deal with and optimize the allostatic response to environmental stressors and exposome. This allows to reduce the dysfunctional adaptive behavior patterns, which underlie many neuropsychological symptoms and pathologies, and to improve the symptoms of depression, anxiety and stress. MATERIALS AND METHODS: From a population of subjects experiencing at least two of the three symptoms depression, anxiety and stress, the selection of pre and post-treatment Depression, Anxiety, Stress 21 items scale (DASS 21) data was made proceeding with a reverse chronological recruitment mechanism, until reaching 150 subjects for each of the 2 groups. The first group was treated with the neuro psycho physical optimization treatment (NPPO), which is the punctiform modality of administration on the auricle pavilion, and the second group was treated with the neuro psycho physical optimization treatment, which is the area modality of administration applied by the planar probe on the cervicobrachial area (NPPO-CB). RESULTS: The Wilcoxon signs test confirmed the differences in scores in pre and post-treatment DASS-21. The comparison between the two groups data and the comparison across groups data showed that NPPO and NPPO-CB have the same efficacy in reducing the symptoms of depression, anxiety and stress, after a single treatment cycle. Statistical significance was set at p <0.05. DISCUSSION: This is the first efficacy descriptive comparison between the two different modalities of administration of the NPPO treatment, as different options for the same clinical indication. Dove 2020-12-21 /pmc/articles/PMC7762445/ /pubmed/33376420 http://dx.doi.org/10.2147/PRBM.S287143 Text en © 2020 Pinheiro Barcessat et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Pinheiro Barcessat, Ana Rita
Nolli Bittencourt, Marina
Góes Gonçalves, Rebeca
Goncalves de Oliveira Cruz, Ana Vitoria
Coelho Pereira, José Alfredo
Bechelli, Fabio Augusto
Rinaldi, Arianna
REAC Neuromodulation Treatments in Depression, Anxiety and Stress. A Comparative Retrospective Study
title REAC Neuromodulation Treatments in Depression, Anxiety and Stress. A Comparative Retrospective Study
title_full REAC Neuromodulation Treatments in Depression, Anxiety and Stress. A Comparative Retrospective Study
title_fullStr REAC Neuromodulation Treatments in Depression, Anxiety and Stress. A Comparative Retrospective Study
title_full_unstemmed REAC Neuromodulation Treatments in Depression, Anxiety and Stress. A Comparative Retrospective Study
title_short REAC Neuromodulation Treatments in Depression, Anxiety and Stress. A Comparative Retrospective Study
title_sort reac neuromodulation treatments in depression, anxiety and stress. a comparative retrospective study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762445/
https://www.ncbi.nlm.nih.gov/pubmed/33376420
http://dx.doi.org/10.2147/PRBM.S287143
work_keys_str_mv AT pinheirobarcessatanarita reacneuromodulationtreatmentsindepressionanxietyandstressacomparativeretrospectivestudy
AT nollibittencourtmarina reacneuromodulationtreatmentsindepressionanxietyandstressacomparativeretrospectivestudy
AT goesgoncalvesrebeca reacneuromodulationtreatmentsindepressionanxietyandstressacomparativeretrospectivestudy
AT goncalvesdeoliveiracruzanavitoria reacneuromodulationtreatmentsindepressionanxietyandstressacomparativeretrospectivestudy
AT coelhopereirajosealfredo reacneuromodulationtreatmentsindepressionanxietyandstressacomparativeretrospectivestudy
AT bechellifabioaugusto reacneuromodulationtreatmentsindepressionanxietyandstressacomparativeretrospectivestudy
AT rinaldiarianna reacneuromodulationtreatmentsindepressionanxietyandstressacomparativeretrospectivestudy